Commentary: Folly of FDA-approval studies for bone morphogenetic protein

Spine Journal

Volumn 11, Issue 6, 2011, Pages 495-499

  Mirza, Sohail K ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; PLACEBO; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

BACKACHE; CLINICAL TRIAL; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; EDEMA; FOOD AND DRUG ADMINISTRATION; HUMAN; NOTE; OSWESTRY DISABILITY INDEX; PAIN; PRIORITY JOURNAL; RADICULITIS; SEXUAL DYSFUNCTION; SWELLING; URINARY DYSFUNCTION; CLINICAL TRIAL (TOPIC); CONFLICT OF INTEREST; METHODOLOGY; SPINE FUSION; STANDARD;

BONE MORPHOGENETIC PROTEIN 2; CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; HUMANS; RECOMBINANT PROTEINS; RESEARCH DESIGN; SPINAL FUSION; TRANSFORMING GROWTH FACTOR BETA;

EID: 79960022000     PISSN: 15299430     EISSN: 18781632     Source Type: Journal    
DOI: 10.1016/j.spinee.2011.05.009     Document Type: Note

References (24)

1. E.J. Carragee, E.L. Hurwitz, and B.K. Weiner A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned Spine J 11 2011 471 491
2. S.D. Boden, T.A. Zdeblick, H.S. Sandhu, and S.E. Heim The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report Spine 25 2000 376 381 (Pubitemid 30097051)
3. S.D. Boden, J. Kang, H. Sandhu, and J.G. Heller Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies Spine 27 2002 2662 2673 (Pubitemid 35425320)
4. J.K. Burkus, M.F. Gornet, C.A. Dickman, and T.A. Zdeblick Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages J Spinal Disord Tech 15 2002 337 349
5. J.K. Burkus, E.E. Transfeldt, and S.H. Kitchel Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2 Spine 27 2002 2396 2408 (Pubitemid 35266228)
6. D.S. Baskin, P. Ryan, and V. Sonntag A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate Spine 28 2003 1219 1224 discussion 1225 (Pubitemid 36734609)
7. J.K. Burkus, S.E. Heim, M.F. Gornet, and T.A. Zdeblick Is INFUSE bone graft superior to autograft bone? An integrated analysis of clinical trials using the LT-CAGE lumbar tapered fusion device J Spinal Disord Tech 16 2003 113 122
8. R.W. Haid Jr., C.L. Branch Jr., J.T. Alexander, and J.K. Burkus Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages Spine J 4 2004 527 538 discussion 538-9 (Pubitemid 40029169)
9. M. Boakye, P.V. Mummaneni, and M. Garrett Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein J Neurosurg Spine 2 2005 521 525
10. J.K. Burkus, H.S. Sandhu, M.F. Gornet, and M.C. Longley Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery J Bone Joint Surg Am 87 2005 1205 1212
11. J.R. Dimar, S.D. Glassman, K.J. Burkus, and L.Y. Carreon Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft Spine 31 2006 2534 2539 discussion 2540 (Pubitemid 44632234)
12. S.D. Glassman, J.R. Dimar 3rd, and K. Burkus The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers Spine 32 2007 1693 1698 (Pubitemid 47051857)
13. E. Dawson, H.W. Bae, and J.K. Burkus Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial J Bone Joint Surg Am 91 2009 1604 1613
14. J.R. Dimar 2nd, S.D. Glassman, and J.K. Burkus Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis J Bone Joint Surg Am 91 2009 1377 1386
15. R.B. D'Agostino Sr., J.M. Massaro, and L.M. Sullivan Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics Stat Med 22 2003 169 186 (Pubitemid 36163579)
16. P. Fritzell, O. Hagg, P. Wessberg, and A. Nordwall 2001 Volvo Award Winner in Clinical Studies: lumbar fusion versus nonsurgical treatment for chronic low back pain: a multicenter randomized controlled trial from the Swedish Lumbar Spine Study Group Spine 26 2001 2521 2532 discussion 2532-4
17. J.I. Brox, O. Reikeras, and O. Nygaard Lumbar instrumented fusion compared with cognitive intervention and exercises in patients with chronic back pain after previous surgery for disc herniation: a prospective randomized controlled study Pain 122 2006 145 155
18. J.I. Brox, R. Sorensen, and A. Friis Randomized clinical trial of lumbar instrumented fusion and cognitive intervention and exercises in patients with chronic low back pain and disc degeneration Spine 28 2003 1913 1921 (Pubitemid 37082653)
19. J. Fairbank, H. Frost, and J. Wilson-MacDonald Randomised controlled trial to compare surgical stabilisation of the lumbar spine with an intensive rehabilitation programme for patients with chronic low back pain: the MRC spine stabilisation trial BMJ 330 2005 1233
20. N.S. Weiss Clinical epidemiology: the study of the outcome of illness 2nd ed. 1996 Oxford University Press New York, NY
21. H.T. Aro, S. Govender, and A.D. Patel Recombinant human bone morphogenetic protein-2: a randomized trial in open tibial fractures treated with reamed nail fixation J Bone Joint Surg Am 93 2011 801 808
22. E.A. Codman The shoulder 1934 Thomas Todd Co. Boston, MA
23. S. Blumenthal, P.C. McAfee, and R.D. Guyer A prospective, randomized, multicenter Food and Drug Administration investigational device exemptions study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: part I: evaluation of clinical outcomes Spine 30 2005 1565 1575 discussion E387-91 (Pubitemid 41024950)
24. J. Zigler, R. Delamarter, and J.M. Spivak Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease Spine 32 2007 1155 1162 discussion 1163 (Pubitemid 46743014)